Fasoracetam Powder: molecular data, studies & sources

Fasoracetam Powder is catalogued here as a research compound. This profile brings together the molecular source record, selected indexed publications and available supplier comparisons. Evidence for a named substance does not authenticate a commercial product.

Compiled by PeptideTech Editors · Sources checked 2026-09-21 · Selected bibliography, not a systematic review

Molecular formula, weight & structure

Molecular formula (MF): C10H16N2O2
Molecular weight (MW): 196.25 g/mol
PubChem compound ID: 198695
Record title: Fasoracetam

Values describe the selected PubChem molecular entity. Counterions, salt forms, hydration and sequence changes can alter the supplied material. Confirm the exact identity against the supplier specification.

Source: PubChem CID 198695 · retrieved 2026-09-21

PubChem 2D molecular structure for Fasoracetam Powder, CID 198695 — 2D depiction from PubChem. Open to inspect the full image. This drawing represents the selected record, not a vendor batch test.

Chemical identifiers and source data

IUPAC name: (5R)-5-(piperidine-1-carbonyl)pyrrolidin-2-one
InChIKey: GOWRRBABHQUJMX-MRVPVSSYSA-N
SMILES: C1CCN(CC1)C(=O)[C@H]2CCC(=O)N2

Machine-readable PubChem source

Human and clinical studies

Selected human-study records are shown with their indexed or reviewed study type. Check the original article for the intervention, formulation and controls; the molecule can also be a comparator or measured variable.

Human study · PubMed trial index
Fasoracetam in adolescents with ADHD and glutamatergic gene network variants disrupting mGluR neurotransmitter signaling.
Elia J, Ungal G, Kao C et al. · Nature communications · 2018
PMID 29339723 · DOI: 10.1038/s41467-017-02244-2

Preclinical research, reviews & other publications

Animal studies, laboratory experiments, reviews and other indexed papers answer different questions. A review is secondary evidence; a case report does not estimate how often an outcome occurs.

Research publication · design requires review
Fasoracetam. LAM 105, NS 105.
· Drugs in R&D · 1999
PMID 10820660 · DOI: 10.2165/00126839-199902020-00014
Research publication · design requires review
A Study of Fasoracetam's Solid State Forms: A Potential Anti-Alzheimer Pharmaceutical.
Harmsen B, Robeyns K, Wouters J et al. · Journal of pharmaceutical sciences · 2017
PMID 28109793 · DOI: 10.1016/j.xphs.2017.01.016

Fasoracetam Powder supplier sources

Scientific sources describe molecules and experiments. The commercial links below identify recorded supplier packages. A publication or chemical database entry does not verify the seller, purity, sterility or contents of a lot. Some links are affiliate links; see our disclosure.

Compare all Fasoracetam Powder sizes, forms and supplier prices →

Supplier	Recorded packages	Example source listing
Amino USAUSD	1000mg Powder · 5000mg Powder2 recorded offers	1000mg Powder · $14.40Checked Sep 16, 2026Supplier listing

Reference sources & further reading

PubChem compound record 198695 — chemical identity and structure.
Wikipedia: Fasoracetam — Background encyclopedia; not a primary clinical source.

The citations above link directly to publication records. Encyclopedia links are background reading and are not used to establish clinical effectiveness.

Search for additional research

These links run searches; their results have not been individually reviewed and can include unrelated compounds.

Research information is not a dosing guide or a recommendation for personal use. Study findings are specific to the formulation, population and methods tested. Read our source and correction policy.